DrugRepV_5508 | Amuvatinib | NA | Cancer | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Investigational | 31786250 |
DrugRepV_5509 | Antimycin A | Antifungal | Fungal infections | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | NA | 31786250 |
DrugRepV_5510 | Azoxystrobin | NA | Fungal infections | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Experimental | 31786250 |
DrugRepV_5511 | Buparvaquone | NA | NA | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | NA | 31786250 |
DrugRepV_5512 | Dequalinium chloride hydrate | NA | NA | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | NA | 31786250 |
DrugRepV_5513 | Manassantin A | NA | NA | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | NA | 31786250 |
DrugRepV_5514 | Monensin sodium salt | NA | NA | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Experimental, Vet approved | 31786250 |
DrugRepV_5515 | Mubritinib | NA | Lung Neoplasm, Renal Neoplasm, Breast Neoplasm, Ovarian Neoplasm, and Pancreatic Neoplasm | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Investigational | 31786250 |
DrugRepV_5516 | Narasin | Antibacterial | Parasitic and bacterial infections | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Experimental | 31786250 |
DrugRepV_5517 | Papaverine hydrochloride | Genito Urinary System and Sex Hormones | Impotence | Vasospasms | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Approved, Investigational | 31786250 |
DrugRepV_5518 | Pimozide | Nervous System | Tourette Disorder | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Approved | 31786250 |
DrugRepV_5519 | Rotenone | NA | NA | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Vet approved | 31786250 |
DrugRepV_5520 | Spautin-1 | NA | NA | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | NA | 31786250 |
DrugRepV_5521 | Valinomycin | NA | NA | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Experimental | 31786250 |
DrugRepV_5522 | Ziprasidone | Nervous System | Schizophrenia | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Approved | 31786250 |
DrugRepV_5523 | Tryptanthrin | NA | NA | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | NA | 31786250 |
DrugRepV_5524 | Ribavirin | Antiinfectives For Systemic Use | Hepatitis C virus | Lassa virus | NA | NA | Gaussia luciferase (Gluc) Glow assay | Decrease (50 %) | Approved | 31786250 |